2p5h
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /><applet load="2p5h" size="350" color="white" frame="true" align="right" spinBox="true" caption="2p5h" /> '''sPLA2 inhibitor 9'''<br /> ==Overview== Sec...)
Next diff →
Revision as of 09:39, 23 January 2008
|
sPLA2 inhibitor 9
Overview
Secretory phospholipase A2 (sPLA2) and matrix metallopreoteinases (MMPs), are key enzymes involved in rheumatoid arthritis (RA), and their, modulation thus represents a potential therapeutic option. On the basis of, Escherichia coli radioassay, synthetic peptides were designed and screened, for sPLA2 inhibition. The linear peptide, 10f (PIP-18), inhibited the, recombinant human synovial sPLA2 activity with an IC50 of 1.19 muM. Not, only did the peptide interfere with the function of sPLA2, but it also, appeared to inhibit mRNA expression of sPLA2 and various MMPs in, IL-1beta-stimulated RA synovial fibroblast (RASF) cultures and thereby the, production of the corresponding proteins (>80% inhibition). Nuclear, magnetic resonance (NMR), modeling, and docking studies indicate that in, solution the peptide exhibits a beta-turn at residues Trp-Asp-Gly-Val and, possibly binds to the hydrophobic channel of sPLA2. The results strongly, suggest that the modulatory action of peptide 10f may play a major role in, counteracting the development of RA.
About this Structure
2P5H is a Protein complex structure of sequences from [1]. Full crystallographic information is available from OCA.
Reference
Novel Peptide Inhibitors of Human Secretory Phospholipase A2 with Antiinflammatory Activity: Solution Structure and Molecular Modeling., Thwin MM, Satyanarayanajois SD, Nagarajarao LM, Sato K, Arjunan P, Ramapatna SL, Kumar PV, Gopalakrishnakone P, J Med Chem. 2007 Nov 1;. PMID:17973469
Page seeded by OCA on Wed Jan 23 11:39:56 2008
